Literature DB >> 15477709

Endocrine tumors of the gut and pancreas tumor biology and classification.

G Rindi1, G Klöppel.   

Abstract

The endocrine tumors of the gut and pancreas tract are a group of neoplasms composed of cells with a neuroendocrine phenotype. Well-differentiated tumors, well-differentiated carcinomas and poorly differentiated carcinomas are the major categories identified. According to their localization (stomach, duodenum-jejunum, ileum, appendix and colorectum), they display distinct phenotypes, regarding their pathology, immunohistochemistry and hormonal syndromes. Their clinical behavior spans from benign, uncertain malignant potential, low-grade malignant to high-grade malignant. Currently, extensive work is performed to unravel the genetic background.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15477709     DOI: 10.1159/000080733

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  21 in total

Review 1.  Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies.

Authors:  Robert T Jensen; Marc J Berna; David B Bingham; Jeffrey A Norton
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

Review 2.  Classification, clinicopathologic features and treatment of gastric neuroendocrine tumors.

Authors:  Ting-Ting Li; Feng Qiu; Zhi Rong Qian; Jun Wan; Xiao-Kun Qi; Ben-Yan Wu
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

Review 3.  Update on the management of gastroenteropancreatic neuroendocrine tumors with emphasis on the role of imaging.

Authors:  Kyung Won Kim; Katherine M Krajewski; Mizuki Nishino; Jyothi P Jagannathan; Atul B Shinagare; Sree Harsha Tirumani; Nikhil H Ramaiya
Journal:  AJR Am J Roentgenol       Date:  2013-10       Impact factor: 3.959

4.  A series of 64 cases of pancreatic cystic neoplasia from an institutional study of China.

Authors:  Yuan Ji; Wen-Hui Lou; Da-Yong Jin; Tian-Tao Kuang; Meng-Su Zeng; Yun-Shan Tan; Hai-Ying Zeng; Akesu Sujie; Xiong-Zeng Zhu
Journal:  World J Gastroenterol       Date:  2006-12-07       Impact factor: 5.742

5.  Cost-utility estimation of surgical treatment of pancreatic carcinoma aimed at cure.

Authors:  David Ljungman; Kent Lundholm; Anders Hyltander
Journal:  World J Surg       Date:  2011-03       Impact factor: 3.352

6.  Secretagogin, a novel neuroendocrine marker, has a distinct expression pattern from chromogranin A.

Authors:  Maode Lai; Bingjian Lü; Xiaoming Xing; Enping Xu; Guoping Ren; Qiong Huang
Journal:  Virchows Arch       Date:  2006-09-06       Impact factor: 4.064

Review 7.  Gut hormones: emerging role in immune activation and inflammation.

Authors:  W I Khan; J E Ghia
Journal:  Clin Exp Immunol       Date:  2010-04-09       Impact factor: 4.330

8.  Diagnosis and treatment of gastrinoma in the era of proton pump inhibitors.

Authors:  Matthias Banasch; Frank Schmitz
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

Review 9.  Diagnosis and treatment of gastric neuroendocrine tumours.

Authors:  Ursula Plöckinger
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

Review 10.  Use of molecular targeted agents for the diagnosis, staging and therapy of neuroendocrine malignancy.

Authors:  R J Hicks
Journal:  Cancer Imaging       Date:  2010-10-04       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.